Next we examined the energy-dependence of p97-catalyzed unfolding. UbL Ub-2 4 5 UbL Ub-GFP was not unfolded by p97 in the absence of nucleotide, and ADP or 2 4 6 the nonhydrolyzable ATP analog ATPγS could not substitute for ATP ( Fig. 4A ).
4 7
Two p97 ATPase inhibitors, the allosteric inhibitor NMS-873 (80) and the D2-2 4 8 specific, ATP-competitive inhibitor , also prevented ATP-dependent 2 4 9 substrate processing ( Fig. 4A ). p97 with a D1 domain Walker B motif mutation 2 5 0 (p97-E305Q) that blocks nucleotide hydrolysis but not binding exhibited only mild 2 5 1 defects in substrate unfolding. By contrast, the same mutation in D2 (p97-2 5 2 E578Q) completely abolished unfoldase activity ( Fig. 4B ; Table 1 ). Together, 2 5 3 these data demonstrate that ATP hydrolysis in D2 powers the unfolding of Ub-UbL Ub-GFP did not alter the ATPase activity of p97 ( Fig. S7A ). Whereas 2 6 0 UN did not significantly affect the ATPase activity of p97, the further addition of 2 6 1 UbL Ub-UbL Ub-GFP stimulated ATP hydrolysis by ~4-fold, whereas Ub-GFP and 2 6 2 Ub3 Ub-GFP had no effect (Fig. 4C) . The latter result is consistent with the inability 2 6 3 1 0 of p97•UN to unfold Ub-GFP or Ub3 Ub-GFP. Neither NSFL1C nor UBXN7 2 6 4 supported substrate-triggered acceleration of p97 ATP hydrolysis ( Fig. S7B ).
6 5
Long, unanchored Ub chains also stimulated p97 ATPase activity to a similar 2 6 6 degree as UbL Ub-UbL Ub-GFP, suggesting that p97 interaction with Ub chains and 2 6 7 not the GFP substrate itself was both necessary and sufficient for the observed 2 6 8 acceleration. In agreement with the unfolding results, the residual ATPase 2 6 9 activity of p97-E578Q was unaffected by substrate plus UN (Fig. 4D ). However, 2 7 0 p97-E305Q, which was able to unfold substrate, was also not stimulated by 2 7 1 substrate, even showing a slight decrease in ATPase activity (Fig. 4D ). The 2 7 2 E305Q mutant also showed higher basal ATPase activity than WT, as has been 2 7 3 seen before in steady-state experiments (20). These results suggest that there is 2 7 4 a high degree of crosstalk between ATPase activity in D1 and D2, and whereas 2 7 5 ATP hydrolysis in D2 is the driving force for unfolding, D1 activity is also needed 2 7 6 for substrate-induced ATPase acceleration. The tight correlation between the competence of a substrate to be unfolded and 2 8 1 its ability to accelerate ATP hydrolysis suggests that binding of substrate to p97 2 8 2 may stimulate ATPase activity, leading to substrate unfolding. To further probe 2 8 3 this hypothesis, we evaluated binding of substrate to p97. Immunoprecipitation of 2 8 4 p97 showed that it bound UbL Ub-UbL Ub-GFP substrate in the presence but not in 2 8 5 the absence of UN (Fig. 5A , lanes 4 and 5). Reciprocal immunoprecipitation of 2 8 6 GFP confirmed that substrate bound UN in the absence of p97 but did not bind 2 8 7 p97 in the absence of UN (Fig. 5B ). Furthermore, the interaction between p97 2 8 8 and UN appeared to be stabilized by substrate binding (Fig. 5A , lanes 3 and 5).
8 9
We also analyzed substrate dependence of GroEL association with p97, but 2 9 0 observed high background binding to our beads even in the absence of antibody 2 9 1 (lane 1). The binding signal was increased in lanes 6 and 7, but this could be due 2 9 2 to p97, which in our experience is prone to exhibit non-specific binding. Whereas the unfolding of substrate was highly dependent on ATP hydrolysis, 2 9 5 substrate interaction with p97 was not. Immunoprecipitation of FLAG-UbL Ub-FLAG-2 9 6 UbL Ub-GFP pulled down equal amounts of p97 in the absence of added 2 9 7 nucleotide and in the presence of ATP, ATPγS, ATP plus NMS-873, and ATP 2 9 8 plus CB-5083 ( Fig. 5C ). Therefore, p97 does not have to be actively remodeling 2 9 9 substrate in order to effectively form a tight complex. Loss of binding of p97, but 3 0 0 not UN, was seen only with added ADP, which could be due to the large 3 0 1 conformational changes observed for p97 in its ADP-bound state (18) ( Fig. 5C ).
0 2
These results are consistent with previous studies on Ub chain association with p97-A232E is either a more powerful or faster motor. On the other hand, ATPase 3 1 7 activity may increase because of decoupling of the D2 "motor" from the substrate 3 1 8 "load", analogous to pushing in the clutch when an engine is revving in low gear.
1 9
If the former is more accurate we would expect to see increased unfolding by the 3 2 0 mutant protein. Conversely, if the latter is correct, we would expect to see in the assay (Fig. 6A , Table 1 ). This effect is reproducible, because in two 3 2 4 independent sets of preparations, p97-A232E displayed faster unfolding than WT 3 2 5 1 2 p97 ( Fig. 6A and Fig. 6C ). The substrate-induced ATPase acceleration observed 3 2 6 for WT p97 was also observed with p97-A232E (Fig. 6B ). The mutant protein 3 2 7 displays an increased basal rate of ATP hydrolysis and a higher rate in the 3 2 8 presence of substrate compared to WT. thought that the core biochemical activity of p97 that enables its diverse 3 4 5 biological functions is its ability to act as a 'segregase' that segregates 3 4 6 polypeptides from binding partners in multisubunit complexes, or from large 3 4 7 macromolecular structures including ribosomes, membranes, or chromatin.
4 8
Although the mechanism by which p97 exerts segregase activity is not known, 3 4 9 the most economical hypothesis is that it grabs onto the polypeptide to be 3 5 0 segregated and commences to unfold it. However, despite the appeal of this 3 5 1 unifying hypothesis, the ability of wild type p97 to harvest the energy of ATP 3 5 2 hydrolysis to unfold a polypeptide has never been directly demonstrated. We binding by NPLOC4 (25, 48, 49, 82 The second requirement for p97-catalyzed unfolding is the heterodimeric adaptor 
3 9
Prior work has led to conflicting proposals regarding the underlying basis for 4 4 0 pathogenesis in IBMPFD. On the one hand, some studies have emphasized a 4 4 1 reduction in specific biological functions of the mutant p97, including its roles in 4 4 2 endosomal trafficking, autophagy, and elimination of leaky lysosomes (56, 8, 60) .
3
Defects in these processes have been linked to reduced binding of mutant p97 to 4 4 4 UBXD1 (8). On the other hand, IBMPFD mutant proteins hydrolyze ATP at a 4 4 5 faster rate (20, (63) (64) (65) . Whereas it has been speculated that the increase in ATP 
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It is interesting that the increased ATPase activity of p97-E305Q did not cause a 4 6 3 similar increase in unfolding rate, suggesting that the rate of ATP hydrolysis in 4 6 4 D2 does not by itself determine the rate of unfolding. Our experiments were 4 6 5 carried out with pure WT and pure mutant p97, so it will be of interest to study 4 6 6 populations of mixed hexamers of A232E and other IBMPFD mutants, to better 4 6 7 recapitulate the situation that pertains in vivo. Whereas much clearly remains to 4 6 8 be done to further investigate this gain-of-function model, if our proposal is 4 6 9 correct it implies that the clinical-grade p97 inhibitor (81) that renormalized the 4 7 0 activity of the mutant protein may be useful for therapy of IBMPFD and ALS 4 7 1 cases that arise from mutation of p97. can be found in Table S1 . G76V notation has been left out of subsequent mentions of these constructs. added progressively in small amounts over the first eight hours of the reaction.
1 7
For that the levels of p97, adaptor, and GroEL used were at or near saturation 5 4 5
( Figure 2-figure supplement 4) . Other nucleotides and p97 inhibitors were Antibodies used for immunoprecipitation and western blotting are listed in Table   5 5 5 
